Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial.

Jesus VillarJosé M AñónCarlos FerrandoGerardo AguilarTomás MuñozJosé FerreresAlfonso AmbrósCésar AldecoaFernando Suárez-SipmannKevin E ThorpePeter JüniArthur S Slutskynull null

Published in: Trials (2020)

ClinicalTrials.gov NCT04325061 . Registered on 25 March 2020 as DEXA-COVID19.

Keyphrases

acute respiratory distress syndrome
coronavirus disease
sars cov
extracorporeal membrane oxygenation
mechanical ventilation
study protocol
clinical trial
respiratory syndrome coronavirus
low dose
high dose
phase iii
randomized controlled trial
phase ii
intensive care unit
combination therapy